On the recordJune 25, 2018
I believe that those who have criticized the blueprint as insufficient are either responding from a lack of knowledge or purely for political gain.
Source
congress.govI believe that those who have criticized the blueprint as insufficient are either responding from a lack of knowledge or purely for political gain.
Hatch defends the drug pricing blueprint against critics.
Share
More from Orrin Hatch
Understanding what is happening in field and regional offices is critical in the role of executive leader of the agency.
Those backlogs at the Social Security Administration are unacceptable to many, if not most, of us here in the Senate.
It is important to support the ability of retirement plans to honor commitments made to working Americans.